Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
13F holders, Q1 2024
Institutional positions in Cero Therapeutics Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −1 vs. Q4 2023
- Shares held
- 1.67M
- +830.9K (+99.6%) vs. Q4 2023
- Total value
- $4.85M
- −$2.64M (−35.2%) vs. Q4 2023
- New holders
- 8
- 0 more added
- Sold out
- 9
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 11 | $798.7K |
| Q2 2025 | 8 | $2.38M |
| Q1 2025 | 15 | $527.7K |
| Q4 2024 | 21 | $800.3K |
| Q3 2024 | 18 | $320.0K |
| Q2 2024 | 15 | $557.1K |
| Q1 2024 | 9 | $4.85M |
| Q4 2023 | 10 | $7.49M |
| Q3 2023 | 10 | $7.33M |
| Q2 2023 | 13 | $10.6M |
| Q1 2023 | 17 | $12.5M |
| Q4 2022 | 46 | $101.1M |
| Q3 2022 | 66 | $153.0M |
| Q2 2022 | 54 | $144.5M |
| Q1 2022 | 45 | $137.2M |
| Q4 2021 | 36 | $104.2M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ARCH Venture Management, LLC | 1,444,296 | $4.43M | 5.52% | +1,444,296 | New |
| SC China Holding Ltd | 149,999 | $202.5K | 0.02% | +149,999 | New |
| Jane Street Group, LLC | 26,515 | $81.4K | 0.00% | +26,515 | New |
| Birchview Capital, LP | 12,972 | $39.8K | 0.03% | +12,972 | New |
| Geode Capital Management, LLC | 10,588 | $32.5K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 10,500 | $32.0K | 0.02% | +10,500 | New |
| Kestra Private Wealth Services, LLC | 10,000 | $30.7K | 0.00% | +10,000 | New |
| Pineridge Advisors LLC | 300 | $921 | 0.00% | +300 | New |
| JPMorgan Chase & Co | 2 | $6 | 0.00% | +2 | New |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −242,687−100.0% | Sold out |
| Mint Tower Capital Management B.V. | 0 | $0 | 0.00% | −141,089−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −108,103−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −54,600−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −47,936−100.0% | Sold out |
| Berkley W R Corp | 0 | $0 | 0.00% | −47,199−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −26,964−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |